Sick of analyzing data? Effortlessly turn raw data into results with ProNect TPD app.

Targeted protein degradation (TPD) offers a different approach to modulating protein function—by removing proteins from the cell instead of inhibiting their activity. This strategy takes advantage of the cell’s own ubiquitin–proteasome system (UPS) to degrade proteins that play a role in disease or are otherwise hard to target with conventional inhibitors.

Molecules like PROTACs and molecular glues initiate this process by linking a target protein to an E3 ligase, leading to its ubiquitination and degradation. Studying how these degraders work in cells is essential for advancing TPD-based therapies.

Promega supports this research with integrated tools, services, and software to study modulated protein dynamics within the cellular environment. CRISPR-edited HiBiT knock-in cells provide sensitive quantitation of protein abundance in both live-cell and lytic assay formats. HiBiT-based technologies are complemented by NanoBRET® assays to investigate ternary complex formation, target ubiquitination, and compound binding or permeability, as well as the HaloPROTAC3 degrader to assess the biological impact of targeted protein removal—all designed to help you characterize and optimize effective degrader compounds.

View Available Cell LinesDownload List (PDF)

Need help with assay development, compound screening or profiling? Learn more about our targeted protein degradation services.

View TPD Services
undruggable-full-color-dark-bg-1

livecellkineticposter
Explore how NanoBRET®, HiBiT, and ViaScript™ technologies enable live-cell kinetic analysis at every step of the TPD workflow—from ternary complex formation to endpoint degradation.

Download Poster »

 

Need help with Assay Development, Screening or Profiling?

Learn more about our targeted protein degradation services.